Early studies of breast cancer patient cohorts reported opposing results when assessing MCL-1 expression; one study found no association between MCL-1 protein expression and patient outcome38, while another linked high MCL-1 protein with high tumour grade and poor outcome39. Here, MCL1 is linked to neoplasm.